Soltis Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $354K | Sell |
796
-89
| -10% | -$39.6K | 0.03% | 293 |
|
|
2025
Q1 | $429K | Buy |
885
+123
| +16% | +$59.7K | 0.04% | 254 |
|
|
2024
Q4 | $307K | Sell |
762
-16
| -2% | -$6.44K | 0.03% | 285 |
|
|
2024
Q3 | $362K | Buy |
778
+83
| +12% | +$38.6K | 0.04% | 258 |
|
|
2024
Q2 | $326K | Buy |
+695
| New | +$326K | 0.03% | 254 |
|
|
2022
Q3 | – | Sell |
-7,188
| Closed | -$2.03M | – | 252 |
|
|
2022
Q2 | $2.03M | Buy |
7,188
+441
| +7% | +$124K | 0.29% | 84 |
|
|
2022
Q1 | $1.76M | Buy |
+6,747
| New | +$1.76M | 0.24% | 97 |
|